Bioqual Statistics
Total Valuation
Bioqual has a market cap or net worth of 38.63 million. The enterprise value is 44.41 million.
| Market Cap | 38.63M |
| Enterprise Value | 44.41M |
Important Dates
The next estimated earnings date is Friday, September 19, 2025.
| Earnings Date | Sep 19, 2025 |
| Ex-Dividend Date | Oct 7, 2024 |
Share Statistics
Bioqual has 894,416 shares outstanding.
| Current Share Class | 894,416 |
| Shares Outstanding | 894,416 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.79 |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -20.88 |
| EV / Sales | 0.91 |
| EV / EBITDA | 14.73 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.48.
| Current Ratio | 5.08 |
| Quick Ratio | 4.91 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 5.81 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -6.51% |
| Revenue Per Employee | 433,606 |
| Profits Per Employee | -18,825 |
| Employee Count | 113 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -998,234 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.43% in the last 52 weeks. The beta is -0.01, so Bioqual's price volatility has been lower than the market average.
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -40.43% |
| 50-Day Moving Average | 66.10 |
| 200-Day Moving Average | 75.88 |
| Relative Strength Index (RSI) | 17.59 |
| Average Volume (20 Days) | 531 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Bioqual had revenue of 49.00 million and -2.13 million in losses. Loss per share was -2.38.
| Revenue | 49.00M |
| Gross Profit | -4.37M |
| Operating Income | -3.27M |
| Pretax Income | -3.13M |
| Net Income | -2.13M |
| EBITDA | -1.11M |
| EBIT | -3.27M |
| Loss Per Share | -2.38 |
Balance Sheet
The company has 11.72 million in cash and 17.50 million in debt, giving a net cash position of -5.78 million or -6.46 per share.
| Cash & Cash Equivalents | 11.72M |
| Total Debt | 17.50M |
| Net Cash | -5.78M |
| Net Cash Per Share | -6.46 |
| Equity (Book Value) | 36.25M |
| Book Value Per Share | 40.53 |
| Working Capital | 23.42M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -8.93%, with operating and profit margins of -6.68% and -4.34%.
| Gross Margin | -8.93% |
| Operating Margin | -6.68% |
| Pretax Margin | -6.38% |
| Profit Margin | -4.34% |
| EBITDA Margin | -2.27% |
| EBIT Margin | -6.68% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.16%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.16% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.16% |
| Earnings Yield | -5.51% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Oct 28, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
Bioqual has an Altman Z-Score of 3.82.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | n/a |